New Triple-Threat attack on hidden leukemia cells aims to stop relapse
Disease control
Recruiting now
This study is testing whether a new combination of three drugs can safely control hidden leukemia cells and prevent the cancer from coming back in adults with acute myeloid leukemia (AML). The goal is to see if adding a new drug called tagraxofusp to two standard drugs helps elim…
Phase: PHASE1, PHASE2 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC